Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Sep 30 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-sep-30-2021-9

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 30, 2021, titled "Glenmark receives marketing approval for Ryaltris��, an innovative combination nasalspray, in 13 countries across the EU and UK".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases